Condition

Desmoid Fibromatosis clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Desmoid Fibromatosis clinical trials that are recruiting, at sites in 7 countries (most in United States (2), Australia (1), Canada (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Desmoid Fibromatosis clinical trials

StudyPhaseWhereStatusRegistered
Arterial embolization for desmoid fibromatosis — Bologna, BO Recruiting Apr 27, 2025
Observing patients with desmoid-type fibromatosis — New York, New York Recruiting Feb 24, 2020
Gathering health information for younger cancer patients — Birmingham, Alabama and 278 other locations Recruiting Mar 30, 2015

All recruiting trials (3)

Related topics

Carcinoma in SituCentral Nervous System NeoplasmGanglioneuromaLymphoproliferative DisorderMalignant NeoplasmMalignant Solid NeoplasmMyeloproliferative NeoplasmNeuroendocrine Neoplasm

Quick answers

How many Desmoid Fibromatosis clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (2 trials), Australia (1 trial), Canada (1 trial), New Zealand (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.